5.89

7.82% -0.50

After Hours: 5.89

Bausch Health Companies Inc (BHC)

Overview News Price History Option Chain Financials Why BHC Down? Discussions Forecast Stock Split Dividend History

Bausch Health Companies Inc stock is traded at $5.89, with a volume of 4.96M. It is down -7.82% in the last 24 hours and down -11.56% over the past month. Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Previous Close:

$6.39

Open:

$5.77

24h Volume:

4.96M

Relative Volume:

2.48

Market Cap:

$2.18B

Revenue:

$9.47B

Net Income/Loss:

$-178.00M

P/E Ratio:

-12.27

EPS:

-0.48

Net Cash Flow:

$1.01B

1W Performance:

-13.13%

1M Performance:

-11.56%

6M Performance:

-20.73%

1Y Performance:

-2.32%

1-Day Range:

$5.50

$6.01

1-Week Range:

$5.50

$7.10

52-Week Range:

$4.25

$9.85

Bausch Health Companies Inc Stock (BHC) Company Profile

Name

Bausch Health Companies Inc

Sector

Healthcare (1161)

Industry

Drug Manufacturers - Specialty & Generic (83)

Phone

514-744-6792

Address

2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC

Employee

20,700

Twitter

Next Earnings Date

2024-10-30

Latest SEC Filings

BHC's Discussions on Twitter

Compare BHC with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BHC Bausch Health Companies Inc	5.89	2.36B	9.47B	-178.00M	1.01B	-0.48
ZTS Zoetis Inc	145.79	66.25B	9.29B	2.52B	2.28B	5.57
TAK Takeda Pharmaceutical Co Adr	13.72	42.95B	30.08B	710.16M	4.45B	0.2182
HLN Haleon Plc Adr	9.43	43.30B	14.35B	1.85B	0	0.4023
TEVA Teva Pharmaceutical Industries Ltd Adr	15.45	19.30B	16.54B	-1.64B	749.00M	-1.45
NBIX Neurocrine Biosciences Inc	128.23	13.53B	2.41B	305.80M	492.20M	2.95

Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-02-24	Downgrade	Piper Sandler	Neutral → Underweight
Jul-10-24	Initiated	Raymond James	Mkt Perform
Sep-20-23	Upgrade	Jefferies	Hold → Buy
Jun-16-23	Downgrade	TD Cowen	Outperform → Market Perform
Jul-29-22	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Jul-29-22	Downgrade	Truist	Buy → Hold
Jul-28-22	Downgrade	JP Morgan	Overweight → Neutral
Jun-13-22	Resumed	JP Morgan	Overweight
Mar-24-21	Downgrade	BofA Securities	Neutral → Underperform
Feb-17-21	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
Jan-22-21	Downgrade	Piper Sandler	Overweight → Neutral
Sep-17-20	Upgrade	BofA Securities	Underperform → Neutral
Aug-24-20	Reiterated	H.C. Wainwright	Buy
Jun-17-20	Reiterated	H.C. Wainwright	Buy
Apr-24-20	Initiated	Citigroup	Buy
Apr-02-20	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jan-29-20	Downgrade	Wolfe Research	Outperform → Peer Perform
Jan-22-20	Upgrade	Wells Fargo	Underweight → Equal Weight
Dec-12-19	Upgrade	JP Morgan	Neutral → Overweight
Dec-02-19	Initiated	Goldman	Neutral
Oct-25-19	Initiated	Cowen	Outperform
Sep-12-19	Initiated	Guggenheim	Buy
Aug-15-19	Upgrade	TD Securities	Hold → Buy
Jul-19-19	Initiated	Wolfe Research	Outperform
Jun-11-19	Resumed	Barclays	Overweight
May-13-19	Upgrade	JP Morgan	Underweight → Neutral
Mar-20-19	Initiated	SunTrust	Buy
Jan-02-19	Upgrade	Piper Jaffray	Neutral → Overweight
Nov-05-18	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Sep-13-18	Upgrade	Piper Jaffray	Underweight → Neutral

View All

Bausch Health Companies Inc Stock (BHC) Latest News

Jul 31, 2025

Bausch Health Stock Falls on Q2 Earnings Miss, Revenues Beat - Nasdaq

Jul 31, 2025

How strong is Bausch Health Companies Inc. company’s balance sheetBest Dividend Tips With High Returns - jammulinksnews.com

Jul 31, 2025